Aerosol-Mediated Non-Viral Lung Gene Therapy
  • View times: 9
  • |
  • Release time: 2022-03-25
  • aminoglycoside-based cationic lipids
  • cystic fibrosis
  • lipidic formulations
  • lung gene therapy
  • nebulization
  • structure-activity
  • in vivo
Video Introduction

This video is adapted from 10.3390/pharmaceutics14010025

The video shows the experimental procedure used to dose animals via aerosol, which allowed to highlight the potential of aminoglycoside-based cationic liposomes for non-viral lung gene therapy.

All procedures were carried out with personal licenses under protocols (APAFIS #22194-2019092711061392) approved by the Laboratory Animal Care Guidelines and the Institutional Animal Care and Research Advisory Committee at both the University of Oxford (United Kingdom) and the University of Brest (France).

Full Transcript


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Gall, T.L.; Berchel, M.; Mottais, A.; Ghanem, R.; Benvegnu, T.; Montier, T. Aerosol-Mediated Non-Viral Lung Gene Therapy. Encyclopedia. Available online: (accessed on 04 December 2022).
Gall TL, Berchel M, Mottais A, Ghanem R, Benvegnu T, Montier T. Aerosol-Mediated Non-Viral Lung Gene Therapy. Encyclopedia. Available at: Accessed December 04, 2022.
Gall, Tony Le, Mathieu Berchel, Angélique Mottais, Rosy Ghanem, Thierry Benvegnu, Tristan Montier. "Aerosol-Mediated Non-Viral Lung Gene Therapy," Encyclopedia, (accessed December 04, 2022).
Gall, T.L., Berchel, M., Mottais, A., Ghanem, R., Benvegnu, T., & Montier, T. (2022, March 25). Aerosol-Mediated Non-Viral Lung Gene Therapy. In Encyclopedia.
Gall, Tony Le, et al. ''Aerosol-Mediated Non-Viral Lung Gene Therapy.'' Encyclopedia. Web. 25 March, 2022.